Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      ACTIVE_NOT_RECRUITING
      SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
      Description

      This is a randomized, placebo-controlled, study of SPI-62 in subjects with ACTH-dependent Cushing's syndrome caused by a non-adrenal tumor. Subjects will receive each of the following 2 treatments for 24 weeks: SPI-62 and matching placebo with the option of long-term extension.

      Conditions
      Cushing's Syndrome ICushing Disease Due to Increased ACTH SecretionCortisol ExcessCortisol; HypersecretionCortisol OverproductionEctopic ACTH Secretion
      Talk to us